Enzolytics Inc (ENZC)

[docsetc]

3 Pending for FDA approval, only one that is close to final testing for a foreign approval that may induce the matching FDA approval. Monoclonal antibody treatments are fast-packaged products once the final approved design and formula is done.

But as another wise investor mentioned yesterday, that can take time, bureaucratic hoops to finish jumping through and that audit, which could have been done faster for such a small company.

Mid-April is seen as rich catalyst timing right now, but something may break sooner, like a licensing agreement, that does NOT have to wait for an audit.